跳至主要内容
临床试验/JPRN-UMIN000005695
JPRN-UMIN000005695已完成未知

A randomized, open-label, parallel group study to evaluate the efficacy and safety of the oral administration of Bifidobacterium animalis subsp. lactis LKM512 in patients with atopic dermatitis - Efficacy and safety of Bifidobacteria LKM512 in patient with atopic dermatitis

Kyodo Milk Industry Co. Ltd.0 个研究点目标入组 50 人开始时间: 2011年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Patients who are taking oral Bifidobacteria LKM512 daily (2) Patients who were diagnosed as having milk allergy (3) Patients who was enrolled in other trails within a month. (4) Inappropriate cases evaluated by doctors

研究者

相似试验